Societe Generale's Global Chief Economist Wei Yao breaks down the heavy pressure facing central banks around the world as they come up against a mix of inflation risk and higher bond yields. (Source: Bloomberg)
Societe Generale's Global Chief Economist Wei Yao breaks down the heavy pressure facing central banks around the world as they come up against a mix of inflation risk and higher bond yields. (Source: Bloomberg)
Yuliia Kaveshnikova/iStock via Getty Images While US markets have raced to new all-time highs in recent years, not all stocks have participated in the rally. Over the past five years, shares of sequencing solution company Pacific Biosciences of California, Inc. ( PACB ) have lost more than 95%. While the stock more than doubled at one point last year, much of those gains have been wiped out in rec...
Yuliia Kaveshnikova/iStock via Getty Images While US markets have raced to new all-time highs in recent years, not all stocks have participated in the rally. Over the past five years, shares of sequencing solution company Pacific Biosciences of California, Inc. ( PACB ) have lost more than 95%. While the stock more than doubled at one point last year, much of those gains have been wiped out in recent months. Recently, the company reported its Q1 results , featuring a revenue guidance cut for the year, at a time when the company needs to be doing much better. Previous Coverage of the Name I first took a look at Pacific Biosciences last June, with shares trading below a dollar and potentially heading for a reverse split . I detailed how analyst revenue estimates continued to head much lower, and large losses were leading to significant cash burn. The stock has been very volatile since, and even though it has risen almost 25% over that time, that gain actually trails the S&P 500 by a couple of percentage points. A Look at the Q1 Results and Guidance Update For the March period, the company reported revenues of almost $37.2 million. That figure was up very slightly from the year-ago period, but the street was looking for nearly $40 million. Management detailed a record quarter for consumables revenue of $21.8 million but noted that instrument revenues were rather weak. The company has continued to talk about weak government and academic spending, a theme I discussed in my prior article thanks to the current Trump administration. When it comes to the income statement, you really have to look at the non-GAAP numbers. The GAAP ones are really messy, since last year's period had a massive write-down of assets, and this year's one had a decent gain due to the sale of short-read sequencing assets. Overall, the adjusted loss was nearly $36 million in Q1 2026. While that was an improvement from $44.4 million seen a year earlier, it's still nearly a dollar of losses for every do...
悉尼燈光音樂節近90架無人機墜港 險擊中工作人員 主辦單位取消周二及周三表演 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】澳洲的悉尼燈光音樂節舉行期間,近90架無人機從空中墜落。主辦單位因應事故,取消周二及三的...
悉尼燈光音樂節近90架無人機墜港 險擊中工作人員 主辦單位取消周二及周三表演 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】澳洲的悉尼燈光音樂節舉行期間,近90架無人機從空中墜落。主辦單位因應事故,取消周二及三的無人機表演。 閃亮發光的無人機在悉尼達令港上空進行「星際之旅」表演時,多架無人機忽然從高空墜落,跌入水中並濺起水花。有目擊者表示,多名工作人員近乎被無人機擊中。負責操作的英國無人機公司表示,由於無線電頻率出現意外的變化,令多架無人機啟動失效安全降落程序,強調沒有無人機脫離安全範圍。